The global cryogenic equipment market will exceed US$22 billion by 2022, according to a Grand View Research report.
Advances in cryogenic gases, metal technology, and demand in a variety of industries will drive demand for cryogenic equipment. The report says, “Widespread usage of cryogens in the food processing industry and transportation of frozen food is also expected to provide avenues for market growth over the next few years. These equipment are widely used in several medical applications such as Magnetic Resonance Imaging (MRI) and dead cell preservation. In addition, they are also used in blood banks owing to growing need for rare blood storage at very low temperature.”
UPS, a global resource in logistics, is now offering cryogenic shipping to its temperature-sensitive portfolio of products in Europe. Specifically, the company is launching UPS Temperature True® Cryo, providing healthcare customers access to end-to-end product protection and capability to ship parcels in a cryogenic environment. The service includes real-time tracking and intervention, which, when combined with the company’s risk mitigation and global network of control towers, will provide complete visibility for shipments at every stage of the supply chain journey.
The services use Cryoport's cryogenic containers, which allow UPS customers to use liquid nitrogen stored in dry vapor form to keep products frozen at -150°C for 10 days while in transit or storage. When meeting minimum volume levels, shipments can also be paired with UPS Proactive Response® Secure, a financial protection service that provides coverage for these time- and temperature-sensitive shipments.
Jan Denecker, Director of Healthcare Marketing & Strategy, UPS Europe, says, “UPS Temperature True Cryo combines innovative packaging, 24/7 monitoring and intervention capabilities for the most critical time- and temperature-sensitive specimens across tissue engineering, regenerative medicine, gene therapy, biopharmaceutical research and reproductive health.”
